Shares of bioMérieux S.A. (OTCMKTS:BMXMF) rose 2.4% during trading on Tuesday . The stock traded as high as $110.11 and last traded at $110.11. Approximately 50 shares changed hands during trading, a decline of 69% from the average daily volume of 163 shares. The stock had previously closed at $107.50.
BMXMF has been the topic of several analyst reports. Berenberg Bank upgraded bioMérieux from a “sell” rating to a “hold” rating in a report on Friday, June 11th. Zacks Investment Research upgraded bioMérieux from a “sell” rating to a “hold” rating in a report on Tuesday, June 29th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $143.00.
The company has a debt-to-equity ratio of 0.14, a current ratio of 1.80 and a quick ratio of 1.21. The firm’s 50-day moving average is $112.56.
bioMÃ©rieux SA develops and produces in vitro diagnostic solutions for private and hospital laboratories for the diagnosis of infectious diseases. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors.
Featured Story: 12b-1 Fees
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.